K. Maclennan

发表

Diffuse Large B-cell Lymphoma: A Clinicopathologic Analysis of 444 Cases Classified According to the Updated Kiel Classification

B. Nathwani, D. Weisenburger, J. Armitage, 2002, Leukemia & lymphoma.

Chromosomal abnormalities in Hodgkin's disease.

D. Weisenburger, J. Armitage, K. Maclennan, 1989, Blood.

Chromosomal abnormalities in Hodgkin's disease.

D. Weisenburger, J. Armitage, K. Maclennan, 1989, Blood.

Staging lymphoma with CT: comparison of contiguous and alternate 10 mm slice techniques.

P. Robinson, K. Maclennan, J. Spencer, 1998, Clinical radiology.

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

K. Maclennan, D. Linch, P. Hoskin, 2003, The Lancet.

Systemic disturbance in Hodgkin's disease and its relation to histopathology and prognosis (BNLI report No. 30).

K. Maclennan, M. Easterling, A. Jelliffe, 1987, Clinical radiology.

Cutaneous infiltration in T‐cell prolymphocytic leukaemia

K. Maclennan, D. Catovsky, E. Matutes, 1995, The British journal of dermatology.

The management of primary carcinoma of the fallopian tube. Experience of 40 cases

K. Maclennan, J. Denham, 1984, Cancer.

Non-Hodgkin’s lymphoma arising in patients treated for Hodgkin’s disease in the BNLI: A 20-year experience

K. Maclennan, G. Hudson, M. Bennett, 1991 .

Riskofsecond primary cancerafter Hodgkin's disease inpatients inthe British National LymphomaInvestigation: relationships tohostfactors, histology andstageofHodgkin's disease, andsplenectomy

K. Maclennan, A. Swerdlow, A. Douglas, 1993 .

Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.

K. Maclennan, S. Russell, M. Collins, 1993, British Journal of Cancer.

Splenic lymphoma in a patient treated with interleukin-2 and dacarbazine for metastatic melanoma.

K. Maclennan, A. Polliack, E. Shiloni, 1992, Leukemia & lymphoma.

Comparison ofthepotential therapeutic effects ofinterleukin 2or interleukin 4secretion byasingle tumour

K. Maclennan, S. Russell, M. Collins, 1993 .

Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation.

K. Maclennan, G. Vaughan Hudson, B. Vaughan Hudson, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Translocation t(11; 14)(q 13;q32) in chronic lymphoid disorders

K. Maclennan, D. Catovsky, E. Matutes, 1992, Genes, chromosomes & cancer.

HODGKIN-CELL LEUKAEMIA OF B-CELL ORIGIN

K. Maclennan, D. Wright, D. Linch, 1985, The Lancet.

Diagnosis and grading of nodular sclerosing Hodgkin's disease: a study of 2190 patients.

K. Maclennan, G. Vaughan Hudson, B. Vaughan Hudson, 1992, International review of experimental pathology.

The Clinical and Prognostic Relevance of Histopathologic Classification in Hodgkin’s Disease

K. Maclennan, G. Hudson, M. Bennett, 1989 .

Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.

D C Linch, K. Maclennan, D. Cunningham, 1996, Blood.

Association between sarcoidosis and lymphoma revisited.

K. Maclennan, D. Catovsky, E. Matutes, 1996, Journal of clinical pathology.

Eosinophilic granuloma of lymph nodes associated with metastatic papillary carcinoma of the thyroid

K. Maclennan, J. Schofield, N. Alsanjari, 1992, Histopathology.

Comparison of Four Immunochemical Methods For the Measurement of Oestrogen Receptor Levels In Breast Cancer

K. Maclennan, M. Dowsett, J. Mckinna, 1992, Cytopathology : official journal of the British Society for Clinical Cytology.

Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases

K. Maclennan, D. Catovsky, G. Flandrin, 1992, British journal of haematology.

LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial.

K. Maclennan, J. Haybittle, D. Linch, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The pretreatment peripheral blood lymphocyte count in 1100 patients with Hodgkin's disease: the prognostic significance and the relationship to the presence of systemic symptoms.

K. Maclennan, J. Haybittle, A. Jelliffe, 1981, Clinical oncology.

Vasitis nodosa‐a site of arrest of malignant germ cells

K. Maclennan, J. Heaton, 1986, Histopathology.

The presentation haemoglobin level in 1103 patients with Hodgkin's disease (BNLI report no. 21).

K. Maclennan, J. Haybittle, M. Easterling, 1983, Clinical radiology.

The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.

K. Maclennan, D. Catovsky, E. Matutes, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic significance of cytologic subdivision in nodular sclerosing Hodgkin’s disease: An analysis of 1156 patients

K. Maclennan, M. Easterling, A. Jelliffe, 1985 .

The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report no. 22).

K. Maclennan, M. Easterling, A. Jelliffe, 1983, Clinical radiology.

REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX

K. Maclennan, J. Haybittle, F. Hayhoe, 1985, The Lancet.

t(6;12)(q23;q13) and t(10;16)(q22;p11) in a phyllodes tumor of breast.

K. Maclennan, K. Maclennan, B. Gusterson, 1992, Cancer genetics and cytogenetics.

Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases.

K. Maclennan, M. Leyland, G. Vaughan Hudson, 1993, British Journal of Cancer.

The prognostic influence of mediastinal bulk in pathological stage IIA Hodgkin's disease treated initially with radiotherapy.

K. Maclennan, D. Linch, S. Schey, 1989, Clinical oncology (Royal College of Radiologists (Great Britain)).

Hodgkin's disease in two sisters.

K. Maclennan, P. Toghill, S. Maclennan, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.

K. Maclennan, D. Linch, G. Vaughan Hudson, 1994, British Journal of Cancer.

Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: a prematurely terminated British National Lymphoma Investigation randomized trial.

K. Maclennan, D. Linch, B. Hancock, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.

K. Maclennan, J. Haybittle, B. Hancock, 1991, British Journal of Cancer.

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.

K. Maclennan, A. Swerdlow, A. Douglas, 1992, BMJ.

Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.

K. Maclennan, E. Macintyre, D. Linch, 1987, Journal of clinical pathology.

HOMOSEXUAL MEN IN LONDON: LYMPHADENOPATHY, IMMUNE STATUS, AND EPSTEIN‐BARR VIRUS INFECTION

K. Maclennan, I. Weller, R. Tedder, 1984, Annals of the New York Academy of Sciences.

The prognostic significance of age in Hodgkin's disease: examination of 1500 patients (BNLI report no. 23).

K. Maclennan, J. Haybittle, M. Easterling, 1983, Clinical radiology.

Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency.

K. Maclennan, C. Rodeck, H. Simmonds, 1984, Clinical and experimental immunology.

Prenatal diagnosis ofthree cases ofsevere combined immunodeficiency: severe Tcell deficiency during thefirst half ofgestation infetuses withadenosine deaminase deficiency

K. Maclennan, C. Rodeck, D. Linch, 1984 .

Microglial cells in human brain have phenotypic characteristics related to possible function as dendritic antigen presenting cells

K. Maclennan, K. Maclennan, D. Powe, 1989, The Journal of pathology.

Gastric lymphoma associated with mucosal and nodal granulomas: a new differential diagnosis in granulomatous gastritis

K. Maclennan, I. Leach, 1990, Histopathology.

Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).

R. Gascoyne, H. Müller-Hermelink, K. Maclennan, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Multiple lymphomatous polyposis of the gastrointestinal tract

K. Maclennan, P. Isaacson, S. G. Subbuswamy, 1984, Histopathology.

Signet-ring cell lymphoma of bone marrow.

K. Maclennan, D. Talbot, I. Smith, 1994, Journal of clinical pathology.

Localised grade 2 non-Hodgkin's lymphoma: results of treatment with radiotherapy (BNLI Report No. 24).

K. Maclennan, D. Lamb, M. Easterling, 1984, Clinical radiology.

Lymphomas presenting as lumps in the parotid region

K. Maclennan, G. Watkin, M. Hobsley, 1984, The British journal of surgery.

Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy.

K. Maclennan, A. Swerdlow, A. Douglas, 1993, British Journal of Cancer.

The pathology of primary gastrointestinal lymphomas (Report no 10).

K. Maclennan, M. Bennett, A. Tu, 1981, Clinical radiology.

Teaching cases from the Royal Marsden Hospital. Case 6: a man with a large cervical mass.

K. Maclennan, B. Bain, D. Catovsky, 1992, Leukemia and Lymphoma.

HODGKIN-CELL LEUKEMIA OF B-CELL ORIGIN - REPLY

K. Maclennan, D. Linch, E. Huehns, 1985 .

Hypopigmented mycosis fungoides

K. Maclennan, R. Marsden, K. Misch, 1987, Clinical and experimental dermatology.

Inefficacy of calcipotriol In skin metastases from breast cancer

K. Maclennan, D. Talbot, I. Smith, 1993, The Lancet.

Localized grade I non-Hodgkin's lymphoma: results of treatment with radiotherapy alone in 88 patients.

K. Maclennan, N. Spry, D. Lamb, 1989, Clinical oncology (Royal College of Radiologists (Great Britain)).

BCL10 in malignant lymphomas – an evaluation using fluorescence in situ hybridization

K. Maclennan, K. Maclennan, K. Horgan, 2002, The Journal of pathology.

A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.

K. Maclennan, W. Gregory, D. Linch, 1996, British Journal of Cancer.

Multiple lymphomatous polyposis of the gastrointestinal tract

K. Maclennan, L. Lopes, J. Waisberg, 1984, Histopathology.

Suprahyoid Hodgkin's disease stage IA.

K. Maclennan, I. Ellis, P. Toghill, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hodgkin's disease in childhood: the British National Lymphoma Investigation experience (BNLI Report No 27).

K. Maclennan, A. Jelliffe, G. Hudson, 1987, Clinical radiology.

The response to treatment of nodular sclerosing Hodgkin's disease with extranodal involvement.

K. Maclennan, A. Jelliffe, G. Vaughan Hudson, 1982, Clinical radiology.

Vascular changes in irradiated lungs: A morphometric study

K. Maclennan, K. Maclennan, M. Wilkinson, 1989, The Journal of pathology.